Literature DB >> 3779116

Familial occurrence of breast cancer is associated with reduced natural killer cytotoxicity.

D R Strayer, W A Carter, I Brodsky.   

Abstract

A factor in the incidence of spontaneous neoplasms in mice is the endogenous level of natural cell-mediated cytotoxicity. These immunosurveillant or host defense mechanisms are probably under the control of multiple gene products including interferons. We studied natural killer (NK) cytotoxicity using peripheral blood mononuclear cells from 59 normal individuals with either a high (17) or low (42) familial incidence of breast cancer. The K562 cell line was used as target in 51Cr release assays. Three effector: target ratios (6.2:1, 25:1, and 50:1) were studied in quadruplicate using 3, 4 and 5-h incubations. Significantly lower natural killer activity (p less than 0.002) was detected in normal individuals with high familial incidences of breast cancer compared to individuals with low incidences in each of the three separate assays (50:1). The same conclusion was reached whether the data were expressed in terms of lytic units per 10(7) blood mononuclear cells or as % specific 51Cr released. Thus, a relationship was observed between the occurrence of breast cancer in closely related family members and low natural cell-mediated cytotoxicity. This result suggests that defects in NK activity may play a role in the initiation of human breast tumors. However, prospective studies will be necessary to establish whether low NK cell activity is a risk factor for breast cancer.

Entities:  

Mesh:

Year:  1986        PMID: 3779116     DOI: 10.1007/bf01806249

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  15 in total

1.  Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity.

Authors:  K Kuribayashi; S Gillis; D E Kern; C S Henney
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

2.  Natural killer cell reactivity: regulatory interactions and among phorbol ester, interferon, cholera toxin, and retinoic acid.

Authors:  R H Goldfarb; R B Herberman
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

3.  Interleukin-2 augments natural killer cell activity.

Authors:  C S Henney; K Kuribayashi; D E Kern; S Gillis
Journal:  Nature       Date:  1981-05-28       Impact factor: 49.962

4.  Activation of human natural killer cells cytotoxic for human leukemia cells by purified interferon.

Authors:  J M Zarling; L Eskra; E C Borden; J Horoszewicz; W A Carter
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

5.  Low natural cytotoxicity of peripheral blood mononuclear cells in individuals with high familial incidences of cancer.

Authors:  D R Strayer; W A Carter; S D Mayberry; E Pequignot; I Brodsky
Journal:  Cancer Res       Date:  1984-01       Impact factor: 12.701

6.  A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cells.

Authors:  M J Droller; M U Schneider; P Perlmann
Journal:  Cell Immunol       Date:  1978-08       Impact factor: 4.868

7.  Role of NK cells in tumour growth and metastasis in beige mice.

Authors:  J E Talmadge; K M Meyers; D J Prieur; J R Starkey
Journal:  Nature       Date:  1980-04-17       Impact factor: 49.962

8.  Relationship of natural killer cytotoxicity to clinical and biochemical parameters of primary human breast cancer.

Authors:  A Fulton; G Heppner; L Roi; L Howard; J Russo; M Brennan
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

9.  Subsequent cancer in patients with chronic lymphocytic leukemia--a possible immunologic mechanism.

Authors:  M H Greene; R N Hoover; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1978-08       Impact factor: 13.506

10.  Low natural-killer-cell activity in familial melanoma patients and their relatives.

Authors:  P Hersey; A Edwards; M Honeyman; W H McCarthy
Journal:  Br J Cancer       Date:  1979-07       Impact factor: 7.640

View more
  17 in total

Review 1.  Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions.

Authors:  Julia Kravchenko; Emanuela Corsini; Marc A Williams; William Decker; Masoud H Manjili; Takemi Otsuki; Neetu Singh; Faha Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Anna Maria Colacci; Monica Vaccari; Chiara Mondello; A Ivana Scovassi; Jayadev Raju; Roslida A Hamid; Lorenzo Memeo; Stefano Forte; Rabindra Roy; Jordan Woodrick; Hosni K Salem; Elizabeth P Ryan; Dustin G Brown; William H Bisson; Leroy Lowe; H Kim Lyerly
Journal:  Carcinogenesis       Date:  2015-05-22       Impact factor: 4.944

Review 2.  NK cells and cancer: you can teach innate cells new tricks.

Authors:  Maelig G Morvan; Lewis L Lanier
Journal:  Nat Rev Cancer       Date:  2016-01       Impact factor: 60.716

Review 3.  The immune system and inflammation in breast cancer.

Authors:  Xinguo Jiang; David J Shapiro
Journal:  Mol Cell Endocrinol       Date:  2013-06-19       Impact factor: 4.102

4.  The natural product chitosan enhances the anti-tumor activity of natural killer cells by activating dendritic cells.

Authors:  Xinxin Li; Wenjuan Dong; Ansel P Nalin; Yufeng Wang; Pan Pan; Bo Xu; Yibo Zhang; Steven Tun; Jianying Zhang; Li-Shu Wang; Xiaoming He; Michael A Caligiuri; Jianhua Yu
Journal:  Oncoimmunology       Date:  2018-03-13       Impact factor: 8.110

Review 5.  Role of the ITAM-Bearing Receptors Expressed by Natural Killer Cells in Cancer.

Authors:  Hakim Medjouel Khlifi; Sophie Guia; Eric Vivier; Emilie Narni-Mancinelli
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

6.  Tumor growth impedes natural-killer-cell maturation in the bone marrow.

Authors:  John O Richards; Xing Chang; Bradley W Blaser; Michael A Caligiuri; Pan Zheng; Yang Liu
Journal:  Blood       Date:  2006-03-23       Impact factor: 22.113

Review 7.  Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines.

Authors:  R Clarke
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

8.  Genetically predisposed, life style and occurrence of metastatic cancer.

Authors:  Nitya G Chakraborty
Journal:  Indian J Hum Genet       Date:  2007-05

Review 9.  Long-Term Sleep Duration as a Risk Factor for Breast Cancer: Evidence from a Systematic Review and Dose-Response Meta-Analysis.

Authors:  Chunyang Lu; Hao Sun; Jinyu Huang; Songcheng Yin; Wenbin Hou; Junyan Zhang; Yanshi Wang; Yingying Xu; Huimian Xu
Journal:  Biomed Res Int       Date:  2017-10-10       Impact factor: 3.411

10.  Common shared genetic variation behind decreased risk of breast cancer in celiac disease.

Authors:  Emilio Ugalde-Morales; Jingmei Li; Keith Humphreys; Jonas F Ludvigsson; Haomin Yang; Per Hall; Kamila Czene
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.